The CEO of one of the worlds biggest pharmaceutical giants says that he's confident about Ireland's future and points to the “quality” and “work ethic” of its young college grads as a key reason for that beliefI spoke to Eli Lilly's highest-ranking board member, John Lechleiter, moments before he received his second honorary doctorate at University College Cork (UCC) late last monthThe fifty-eight year old, whose remuneration Business Week estimates to be in the region of $16m per annum, said that Ireland's turbulent economic history had not dented his company's enthusiasm for its Kinsale-based operating plant, and seemed extremely keen to emphasize that the talent which the pharmaceutical goliath had been able to attract in Ireland more than made up for any bumps and creases that will undoubtedly crop us along the long and windy road towards Ireland's distant economic recovery“We have been able to get some of the very best people here, graduates to come and work for us, and I think that one reason is that after nearly thirty years of experience operating in Ireland they can see how many of the people who joined us in the 80s and 90s have had flourishing and successful careers with us,” the pharma head, who counts an earned PhD from Harvard among his growing collection of honorary degrees, said ahead of the conferring ceremony Read more
![]()
![]()
![]()
![]()
![]()
↧